Substituted pyridotriazine compounds and uses thereof Grant US-11897892-B2 United States of America 13 Feb 2024
Substituted pyrido[1,2-a]pyrrolo[1,2-d]pyrazines for treating viral infections Grant US-11883397-B2 United States of America 30 Jan 2024
Substituted 1,4-methanopyrido[1′,2′:4,5]pyrazino[1,2-a]pyrimidines for treating viral… Grant US-11548901-B2 United States of America 10 Jan 2023
Substituted pyrido[1,2-a]pyrrolo[1,2-d]pyrazines for treating viral infections Grant US-11213523-B2 United States of America 04 Jan 2022
Crystalline forms of (2R,5S,13aR)-8-hydroxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9… Grant US-11202780-B2 United States of America 21 Dec 2021
Methods of preventing toxicity of platinum drugs Grant US-11197862-B2 United States of America 14 Dec 2021
Synthesis of polycyclic-carbamoylpyridone compounds Grant US-10975096-B2 United States of America 13 Apr 2021
SELECTIVE OCT2 INHIBITORS FOR USE IN PREVENTING TOXICITY OF PLATINUM DRUGS Application EP-3777851-A1 European Patent Office 17 Feb 2021
Substituted 3,4,5,6,8,10,14,14a-octahydro-2h-2,6-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1… Grant US-10689399-B2 United States of America 23 Jun 2020
Polycyclic-carbamoylpyridone compounds and their pharmaceutical use Grant US-10668064-B2 United States of America 02 Jun 2020
Polycyclic-carbamoylpyridone compounds and their pharmaceutical use Grant US-10646486-B2 United States of America 12 May 2020
Synthesis of polycyclic-carbamoylpyridone compounds Grant US-10519168-B2 United States of America 31 Dec 2019
Substituted dipyrido[1,2-a:1′,2′-d]pyrazines for treating viral infections Grant US-10456395-B2 United States of America 29 Oct 2019
Sodium (2R,5S,13aR)-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octa… Grant US-10385067-B2 United States of America 20 Aug 2019
METHODS OF PREVENTING TOXICITY OF PLATINUM DRUGS Application EP-3322414-A4 European Patent Office 06 Feb 2019
Crystalline forms of (2R,5S,13AR)-8-hydroxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9… Grant US-10098886-B2 United States of America 16 Oct 2018
Substituted 2,3,4,5,7,9,13,13a-octahydro-1,5-methanopyrido[1′,2′:4,5]pyrazino[1,2-a][1,3]di… Grant US-10035809-B2 United States of America 31 Jul 2018
Polycyclic-carbamoylpyridone compounds and their pharmaceutical use Grant US-9795602-B2 United States of America 24 Oct 2017
Substituted 2,3,4,5,7,9,13,13a-octahydropyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]OXAZEPINES… Grant US-9732092-B2 United States of America 15 Aug 2017
Sodium (2R,5S,13aR)-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octa… Grant US-9708342-B2 United States of America 18 Jul 2017
Polycyclic-carbamoylpyridone compounds and their pharmaceutical use Grant US-9700554-B2 United States of America 11 Jul 2017
Crystalline forms of (2R,5S,13AR)-8-hydroxy-7,9,-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7… Grant US-9682084-B2 United States of America 20 Jun 2017
Substituted 1,2,3,4,6,8,12,12a-octahydro-1,4-methanodipyrido[1,2-a:1',2'-d]pyrazines and… Grant US-9663528-B2 United States of America 30 May 2017
Polycyclic-carbamoylpyridone compounds and their pharmaceutical use Grant US-9630978-B2 United States of America 25 Apr 2017
METHODS OF PREVENTING TOXICITY OF PLATINUM DRUGS Application WO-2017011816-A1 World Intellectual Property Organisation (WIPO) 19 Jan 2017
Polycyclic-carbamoylpyridone compounds and their pharmaceutical use Grant US-9522912-B2 United States of America 20 Dec 2016
Polycyclic-carbamoylpyridone compounds and their pharmaceutical use Grant US-9421214-B2 United States of America 23 Aug 2016
Substituted 2,3,4,5,7,9,13,13a-octahydropyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepines… Grant US-9216996-B2 United States of America 22 Dec 2015